Jinxin Fertility Group Limited (HKG:1951)
Hong Kong · Delayed Price · Currency is HKD 2.320
+0.050 (2.20%)
At close: Mar 27, 2026
Jinxin Fertility Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,649 | 2,812 | 2,789 | 2,364 | 1,839 | |
Revenue Growth (YoY) | -5.78% | 0.81% | 17.95% | 28.59% | 28.94% |
Cost of Revenue | 1,763 | 1,712 | 1,613 | 1,451 | 1,067 |
Gross Profit | 886.54 | 1,099 | 1,175 | 913.13 | 771.48 |
Selling, General & Admin | 662.71 | 633.18 | 673.23 | 610.29 | 389.45 |
Research & Development | 20.65 | 24.69 | 21.75 | 17.47 | 10.65 |
Operating Expenses | 683.35 | 657.87 | 694.97 | 627.76 | 400.1 |
Operating Income | 203.19 | 441.58 | 480.47 | 285.37 | 371.39 |
Interest Expense | -71.06 | -57.41 | -79.64 | -71.85 | -21.15 |
Interest & Investment Income | 9.39 | 7.48 | 20.71 | 28.35 | 34.45 |
Earnings From Equity Investments | 11.62 | 5.15 | 4.95 | -4.37 | -10.11 |
Currency Exchange Gain (Loss) | -8.7 | -24.17 | 3.99 | 9.42 | 13.12 |
Other Non Operating Income (Expenses) | -8.16 | 24.11 | 27.69 | 15.96 | 29.37 |
EBT Excluding Unusual Items | 136.28 | 396.74 | 458.16 | 262.87 | 417.07 |
Impairment of Goodwill | -631.59 | - | - | - | - |
Gain (Loss) on Sale of Investments | 2.46 | -4.89 | 6.12 | -35.4 | 40.86 |
Gain (Loss) on Sale of Assets | -0.49 | -0.06 | -1.07 | -34.54 | -0 |
Asset Writedown | -360.99 | - | - | - | - |
Other Unusual Items | -128.64 | 0.1 | 1.05 | -38.61 | - |
Pretax Income | -982.96 | 391.89 | 464.27 | 154.32 | 457.93 |
Income Tax Expense | 0.92 | 118.42 | 117.29 | 36.38 | 104.23 |
Earnings From Continuing Operations | -983.89 | 273.47 | 346.98 | 117.95 | 353.7 |
Minority Interest in Earnings | 7.74 | 9.63 | -2.26 | 3.18 | -13.8 |
Net Income | -976.15 | 283.1 | 344.72 | 121.12 | 339.9 |
Net Income to Common | -976.15 | 283.1 | 344.72 | 121.12 | 339.9 |
Net Income Growth | - | -17.88% | 184.60% | -64.37% | 35.08% |
Shares Outstanding (Basic) | 2,742 | 2,681 | 2,676 | 2,496 | 2,478 |
Shares Outstanding (Diluted) | 2,742 | 2,719 | 2,736 | 2,624 | 2,504 |
Shares Change (YoY) | 0.85% | -0.61% | 4.24% | 4.80% | 3.67% |
EPS (Basic) | -0.36 | 0.11 | 0.13 | 0.05 | 0.14 |
EPS (Diluted) | -0.36 | 0.10 | 0.12 | 0.05 | 0.14 |
EPS Growth | - | -18.38% | 154.93% | -64.63% | 35.88% |
Free Cash Flow | - | 366.84 | 510.92 | -417.65 | 263.62 |
Free Cash Flow Per Share | - | 0.14 | 0.19 | -0.16 | 0.10 |
Dividend Per Share | 0.037 | - | 0.050 | - | 0.060 |
Gross Margin | 33.47% | 39.10% | 42.15% | 38.62% | 41.95% |
Operating Margin | 7.67% | 15.71% | 17.23% | 12.07% | 20.20% |
Profit Margin | -36.85% | 10.07% | 12.36% | 5.12% | 18.48% |
Free Cash Flow Margin | - | 13.05% | 18.32% | -17.66% | 14.34% |
EBITDA | 406.67 | 645.06 | 682.02 | 476.22 | 494.08 |
EBITDA Margin | 15.35% | 22.94% | 24.45% | 20.14% | 26.87% |
D&A For EBITDA | 203.48 | 203.48 | 201.55 | 190.85 | 122.7 |
EBIT | 203.19 | 441.58 | 480.47 | 285.37 | 371.39 |
EBIT Margin | 7.67% | 15.71% | 17.23% | 12.07% | 20.20% |
Effective Tax Rate | - | 30.22% | 25.26% | 23.57% | 22.76% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.